Peter Kuipers - May 8, 2024 Form 3 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Signature
Peter J. Rivas as attorney-in-fact for Peter Kuipers
Stock symbol
CLOV
Transactions as of
May 8, 2024
Transactions value $
$0
Form type
3
Date filed
5/10/2024, 04:15 PM
Previous filing
Nov 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLOV Class A Common Stock 6.85M May 8, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported number of securities beneficially owned represents 6,849,315 shares of Class A common stock of Clover Health Investments, Corp. underlying unvested time-based restricted stock units as of May 8, 2024, the effective date of the Reporting Person's appointment as Chief Financial Officer. Twenty-five percent of the restricted stock units vest on the first anniversary of April 29, 2024, and thereafter, the remaining RSUs shall vest on a quarterly basis ending on April 29, 2028, subject to the Reporting Person's continued employment on each such vesting date.

Remarks:

Ex. 24 - Power of Attorney